Navigation Links
Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
Date:5/7/2012

ent of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.  Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced liposomal pulmonary technology in areas of high unmet need.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, results of operations, the status and the results of pre-clinical studies and clinical trials and preclinical and clinical data described herein, the timing of and costs associated with pre-clinical studies and clinical trials, the development of our products, and the business strategies, plans and objectives of management, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  Our results may be affected by such factors as the receipt and timing of FDA and other regulatory reviews and approvals, if at all, competitive developments affecting our product development, delays in product development or clinical trials, and patent disputes involving currently developing products.  The risks and uncertainties include, without limitation, we may experience unexpected regulatory actions, delays or requests, our future clinical trials may not be successful, we may be unsuccessful in developing our product candidates or receiving necessary regulatory approvals, we may experience delays in our product development or clinical trials, our product candidates may not prove to be commercially successful, our expenses may be higher than anticipated and other risk
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insmed to Host 2012 First Quarter Earnings Conference Call
2. Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call
3. Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication
5. Insmed Incorporated Provides Regulatory Update
6. Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
8. Insmeds ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
9. Insmed Announces First Quarter 2011 Financial Results
10. Insmed to Host 2011 First Quarter Earnings Conference Call
11. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Allowing more basic emergency medical service (EMS) staff to ... opioids, according to a Centers for Disease Control and ... Medical Service Providers and the Burden of Drug Overdose ... of Public Health . In 2013, more ... involved prescription opioids, and more than 8,000 ...
(Date:4/24/2015)... 24, 2015 In today,s ever-changing and ... around the world to access diverse skill sets, ... there are many areas to misstep in the ... best practices are necessary and beneficial in order ... According to research by benchmarking firm, Best Practices, ...
(Date:4/24/2015)... , Apr. 24, 2015 Research and ... announced the addition of the "Lab ... tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User ... Global Forecast to 2020" report to ... accessories market is expected to reach $504.7 ...
Breaking Medicine Technology:Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3Work Around the Clock: Building Effective Global Capabilities 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3
... SILVER SPRING, Md., May 13, 2011 The U.S. Food ... represented as "ExtenZe," which is the name of an authentic ... similar to the actual product, but contains hidden ingredients that ... the following lot numbers on the packages: ...
... 13, 2011 Amnis Corporation, a manufacturer of advanced ... new FlowSight imaging flow cytometer. The FlowSight ... unrivalled fluorescence sensitivity and the breakthrough ability to produce ... upgraded in the factory or the field with up ...
Cached Medicine Technology:FDA Warns About Counterfeit ExtenZe Dietary Supplements 2
(Date:4/25/2015)... Bradley, Illinois (PRWEB) April 25, 2015 ... life enrichment and wellness, management and operations, and ... Annual Meeting and Exhibition scheduled to be held ... Illinois. , LeadingAge Illinois is the largest eldercare ... leading providers of services for older adults, including ...
(Date:4/25/2015)... York (PRWEB) April 25, 2015 The URO ... Jerry Blaivas has been chosen by the New York Academy ... contributions to medicine in the field of Urology. , Dr. ... in his speciality, Genito-Urinary diseases. He was a man ... the field of urology. Not only did he devote ...
(Date:4/25/2015)... TX/Minneapolis, MN (PRWEB) April 25, 2015 ... the recipient of RFID Journal’s annual Best Implementation Award. ... that has demonstrated the best use of RFID technology ... The winner is the company that best demonstrates how ... award was presented at RFID Journal Live! 2015 in ...
(Date:4/24/2015)... Bird B Gone, the leader in bird ... a complete line of bird control solutions to address the ... Flu Strains Threaten Pacific, Central and Mississippi Farms , According ... a number of highly pathogenic avian flus in the Pacific, ... spread when wild birds enter poultry farms. The USDA urges ...
(Date:4/24/2015)... County, Illinois (PRWEB) April 24, 2015 ... event includes septic tank pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of ... 3-customers to start the program. This does not include ... be applicable. Save $25-$65 per person. If someone is ... unit, or two tanks totaling approximately 2500 gallons or ...
Breaking Medicine News(10 mins):Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3
... TALLAHASSEE, Fla., Aug. 12 With the recent increase in ... in these already hard economic times - do they pay the ... those who want to quit, The Florida Quitline (1-877-U-CAN-NOW) is here ... , , According to Kim Berfield, Deputy Secretary ...
... , , , , ... a leading provider of Linux-bas e d ... Systems, a national health care management company, has deployed Arkeia Network Backup. ... Goold has realized dramatic improvements in backup performance and in backup administration. ...
... Fountain Healthy Aging,Inc. announced on August 12 2009 that ... Oak Resources Limited which provides the Company,with a $5,000,000 Equity ... has the right to draw down from the Equity Line,Investment ... of 24 months. The,first tranche investment of $1,000,000 was drawn ...
... , WESTFIELD, Ind., Aug. 12 maxIT ... healthcare providers, announced the successful "Stage 6" designation of Gila ... in Silver City, New Mexico. maxIT assisted the Phoenix Health ... to support the implementation of several HIS modules. Beginning ...
... , , , ... (NYSE: HI ) -- Hillenbrand, Inc. reported net revenues of ... 2009, a $6.3 million (3.8 percent) decline from the same period in ... million (4.9 percent) decline. The difference in as-adjusted net income for the ...
... , , , ... create expensive home health care costs. Poorly designed mobility aids or ... issue only part of the need is addressed which creates mobility ... alleviated if mobility issues were detected and properly addressed. , ...
Cached Medicine News:Health News:The Time To Quit Is Now -- Free NRT Is Available 2Health News:Goold Health Systems Accelerates Backups by 5-times Using Arkeia Network Backup 2Health News:Goold Health Systems Accelerates Backups by 5-times Using Arkeia Network Backup 3Health News:Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured 2Health News:Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured 3Health News:maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 2Health News:maxIT Assists Medical Center to Achieve Prestigious Stage 6 Recognition 3Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 2Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 3Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 4Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 5Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 6Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 7Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 8Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 9Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 10Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 11Health News:Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009 12Health News:Expensive Health Care: Undetected, Unmet Mobility Needs Creating Boomer & Senior Health Care Costs 2
Broad tip, gentian violet, sterile, disposable...
Freer elevator, double end, 7 1/4", S/B....
... absorbable gelatin sponge, U.S.P. is a ... sponge intended for hemostatic use by ... sponge is off-white and porous in ... hemostasis, highly favorable surgeon preference ratings ...
16 mm diameter curved probes with suture eyes just back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.7 inches....
Medicine Products: